These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 31741026)

  • 1. Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study.
    Sorrentino L; Guaglio M; Battaglia L; Bonfanti G; Vitellaro M; Bianchi AC; Milione M; Belli F
    Int J Colorectal Dis; 2019 Dec; 34(12):2161-2169. PubMed ID: 31741026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of preoperative chemoradiotherapy and upfront surgery in the treatment of upper-half rectal cancer: oncological benefits, surgical outcomes, and cost implications.
    Wang Y; Wang X; Chen J; Huang S; Huang Y
    Updates Surg; 2024 Jun; 76(3):949-962. PubMed ID: 38240957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
    Lin Y; Lin H; Xu Z; Zhou S; Chi P
    J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.
    Ide S; Toiyama Y; Okugawa Y; Oki S; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Kobayashi M; Ohi M; Araki T; Kusunoki M
    Anticancer Res; 2017 Oct; 37(10):5797-5804. PubMed ID: 28982904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.
    Park IJ; You YN; Agarwal A; Skibber JM; Rodriguez-Bigas MA; Eng C; Feig BW; Das P; Krishnan S; Crane CH; Hu CY; Chang GJ
    J Clin Oncol; 2012 May; 30(15):1770-6. PubMed ID: 22493423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer.
    Schou JV; Larsen FO; Sørensen BS; Abrantes R; Boysen AK; Johansen JS; Jensen BV; Nielsen DL; Spindler KL
    Ann Oncol; 2018 Mar; 29(3):610-615. PubMed ID: 29253083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy.
    Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S
    Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant (re)chemoradiation for locally recurrent rectal cancer: Impact of anatomical site of pelvic recurrence on long-term results.
    Sorrentino L; Belli F; Valvo F; Villa S; Guaglio M; Scaramuzza D; Gronchi A; Di Bartolomeo M; Cosimelli M
    Surg Oncol; 2020 Dec; 35():89-96. PubMed ID: 32858390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delay to Adjuvant Chemotherapy: Survival and Recurrence in Patients of Rectal Cancer Treated with Neo-adjuvant Chemoradiotherapy and Surgery.
    Thong DW; Kim J; Naik A; Lu CT; Nolan GJ; Von Papen M
    J Gastrointest Cancer; 2020 Sep; 51(3):877-886. PubMed ID: 31691086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant treatment for resected rectal cancer: impact of standard and intensified postoperative chemotherapy on disease-free survival in patients undergoing preoperative chemoradiation-a propensity score-matched analysis of an observational database.
    Garlipp B; Ptok H; Benedix F; Otto R; Popp F; Ridwelski K; Gastinger I; Benckert C; Lippert H; Bruns C
    Langenbecks Arch Surg; 2016 Dec; 401(8):1179-1190. PubMed ID: 27830368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between diabetes and oncological outcomes in patients undergoing neoadjuvant chemo-radiotherapy for rectal cancer.
    Fransgaard T; Hallas J; Thygesen LC; Gögenur I
    Surg Oncol; 2019 Mar; 28():62-66. PubMed ID: 30851913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Neoadjuvant Rectal Score and Indication for Postoperative Adjuvant Therapy in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy.
    Maeda K; Shibutani M; Tachimori A; Nishii T; Aomatsu N; Fukuoka T; Nagahara H; Otani H; Inoue T; Ohira M
    In Vivo; 2020; 34(1):283-289. PubMed ID: 31882490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No benefit after neoadjuvant chemoradiation in stage IV rectal cancer: A propensity score-matched analysis on a real-world population.
    Milito P; Sorrentino L; Pietrantonio F; Di Russo A; Citterio D; Mazzaferro V; Cosimelli M
    Dig Liver Dis; 2021 Aug; 53(8):1041-1047. PubMed ID: 33487580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical staging accuracy and the use of neoadjuvant chemoradiotherapy for cT3N0 rectal cancer: Propensity score matched National Cancer Database analysis.
    Burneikis D; Lavryk O; Gorgun E; Liska D; Valente M; Sklow B; Kalady M; Steele SR
    Am J Surg; 2021 Mar; 221(3):561-565. PubMed ID: 33223074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluation of Preoperative Chemoradiotherapy for Clinical T3 Lower Rectal Cancer: A Multicenter Collaborative Retrospective Clinical Study.
    Takeda M; Kawahara H; Ogawa M; Suwa K; Eto K; Yanaga K
    Anticancer Res; 2019 Jun; 39(6):3047-3052. PubMed ID: 31177147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
    Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
    Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of treatment response and tissue necrosis as prognostic indicators following neoadjuvant chemoradiotherapy in rectal cancer patients.
    Jung JH; An HJ; Kim HJ; Lee J; Lee KM; Kim SH; Cho HM; Shim BY
    Korean J Intern Med; 2016 Jan; 31(1):134-44. PubMed ID: 26767867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis in rectal carcinoma after neoadjuvant chemoradiation: various methods with different results.
    Merkel S; Weber K; Göhl J; Agaimy A; Fietkau R; Hohenberger W; Grützmann R; Hermanek P
    Int J Colorectal Dis; 2017 Sep; 32(9):1295-1301. PubMed ID: 28730369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.